Menu
Moyra Mortbyprofile image
Dr

Moyra Mortby


Current Appointments

Research Fellow
email hidden; JavaScript is required

Dr Moyra Mortby is a Psychologist specialised in neuropsychiatric symptoms in dementia and pre-clinical stages of dementia and is an NHMRC-ARC Dementia Research Development Fellow. She was awarded her PhD with Laudatio Magna Cum Laude from the University of Zurich, Switzerland for her research on apathy and depression in Mild Cognitive Impairment and Alzheimer’s disease, and completed her MSc in Research Methods in Psychology and BSc in Criminology and Psychology both at Keele University, UK.

Her research program focuses on neuropsychiatric symptoms in dementia and pre-clinical stages of dementia, neuroimaging and epidemiology. 2015 International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and the Neuropsychiatric Syndromes (NPS) in Neurodegenerative diseases Professional Interest Area (PIA) New Investigator Award.

Her research program is structured around 4 key areas which aim to: 1) improve our understanding of dementia, its risk factors and trajectories; 2) better understand the impact of neuropsychiatric symptoms on dementia trajectories, quality of life and the provision of formal and informal care; 3) validate the concept of Mild Behavioural Impairment as a pre-clinical stage of dementia; and 4) develop and evaluate interventions to reduce neuropsychiatric symptoms associated with dementia, improve quality of life for people living with dementia and those providing care and develop useful support mechanisms.


Publications

2025, 01 Dec

Adapting epidemiological research through unexpected environmental events: COVID-19 and bushfires impacts on the administration of the PATH cohort study

View full journal-article on https://app.dimensions.ai/details/publication/pub.1189785233

2025, 01 Dec

Humor styles and subjective wellbeing in older adults: Identifying mediators and associated implications for healthy aging

View full journal-article on https://app.dimensions.ai/details/publication/pub.1191472132

2025, 24 Nov

Plasma biomarkers in neuropsychiatric syndromes: A narrative review.

View full journal-article on https://app.dimensions.ai/details/publication/pub.1195390707

2025, 01 Sep

Apathy is distinct from depression or fatigue and is associated with poor physical health in an older community cohort

View full journal-article on https://app.dimensions.ai/details/publication/pub.1189188510

2025, 01 Sep

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders

View full journal-article on https://app.dimensions.ai/details/publication/pub.1187991067

2025, 01 Mar

Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease

View full journal-article on https://app.dimensions.ai/details/publication/pub.1186975017

2025, 01 Jan

Maintaining level of modifiable dementia risk scores is associated with better cognitive outcomes than increasing risk scores: A population-based prospective cohort study

View full journal-article on https://app.dimensions.ai/details/publication/pub.1184046398

2024, 01 Dec

Apathy and fatigue, but not depression, associated with inflammatory biomarkers in older adults

View full conference-poster on https://app.dimensions.ai/details/publication/pub.1184077091

2024, 01 Dec

Functional impairment in a dementia‐free sample associated with a higher risk of Mild Behavioral Impairment

View full conference-poster on https://app.dimensions.ai/details/publication/pub.1184067214

2024, 01 Dec

No Association Found: Adverse Childhood Experiences and Cognitive Impairment in Older Australian Adults

View full journal-article on https://app.dimensions.ai/details/publication/pub.1173326629


Menu